" 209.1 
scope and purpose. 
(a) this part sets forth requirements for human prescription drug products approved under section 505 of the federal food, drug, and cosmetic act and dispensed by authorized dispensers and pharmacies to consumers. this part requires distribution of a side effects statement and applies to new and refill prescriptions. this part is not intended to apply to authorized dispensers dispensing or administering prescription drug products to inpatients in a hospital or health care facility under an order of a licensed practitioner, or as part of supervised home health care. 
(b) the purpose of providing the side effects statement is to enable consumers to report side effects of prescription drug products to fda.", 
